glp-1 and gip/glp-1 receptor agonists Understand GLP-1/GIP Dual Agonist Tirzepatide Its Effect on Current Weight Loss Therapy GLP-1 Drug Savings: A Complete

In recent years, there has been an increase in the morbidity, disability rate,and mortality due to obesity, making ...

and increased insulin early AUC and C-peptide total and early AUCs

The FDA has approved Eli Lilly and Companys Foundayo, a GLP-1 weight loss pill that removes one of the biggest barriers in treatmentcomplex dosing

Key Findings: - Increased risk of going over recommended weight gain limits - Higher chances of preterm birth (from 13% to 17%) - Rising cases of gestational diabetes (15% to 20%) - Nearly half faced high blood pressure issues While baby sizes and C-section rates remained similar, the impact on maternal health is significant

In addition to todays resource, please see and review the New York Times article, The Risks of Taking Drugs Like Ozempic When Youre Over 65: Medications that cause drastic weight loss raise specific concerns for older adults